Found 153 matching trials
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer PHASE3 The main purpose of this study is to compare the disease-free survival betw...
Show More Learn More & Join Trial
A Phase 2 Study of Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer PHASE2 Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer PHASE2 This is a phase II, single arm, multi-centre study to assess the efficacy o...
Show More Status
Active Not Recruiting
Location
Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
Learn More & Join Trial
Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System PHASE2 To seek the efficacy signals of trastuzumab in combination with chemotherap...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer PHASE3 This is a Phase IIIb, multinational, multicenter, randomized, open-label st...
Show More Location
Centro de Investigaciones Médicas y Desarrollo LC S.R.L
Learn More & Join Trial
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013) PHASE3 Researchers are looking for new ways to treat Limited-Stage Small Cell Lung...
Show More Status
Active Not Recruiting
Location
Ironwood Cancer & Research Centers ( Site 0007)
Learn More & Join Trial
Endocrine Therapy With Abemaciclib or Chemotherapy as Initial Metastatic Treatment in ER+/HER2- Breast Cancer PHASE3 AMBRE is a phase III study comparing two standard treatments as initial met...
Show More Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Learn More & Join Trial
Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer Setting PHASE2 Test the safety, immune response and efficacy of GVAX pancreas vaccine (wit...
Show More Location
Scottsdale Healthcare Research Institute
Learn More & Join Trial
Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers PHASE2 This novel study was specifically designed for platinum resistant recurrent...
Show More Location
Menoufia University, Faculty of medicine
Learn More & Join Trial
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects PHASE3 This study is a randomized controlled, open-label, multicenter phase III cl...
Show More Learn More & Join Trial